Suppr超能文献

两性霉素B增强阿霉素对MCF-7乳腺癌细胞的抗癌活性。

Amphotericin B potentiates the anticancer activity of doxorubicin on the MCF-7 breast cancer cells.

作者信息

Tavangar Farzaneh, Sepehri Hamid, Saghaeian Jazi Marie, Asadi Jahanbakhsh

机构信息

Student Research Committee, Golestan University of Medical Sciences, Gorgan, Iran.

Neuroscience Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

出版信息

J Chem Biol. 2017 Jun 5;10(3):143-150. doi: 10.1007/s12154-017-0172-1. eCollection 2017 Jul.

Abstract

Despite the improvements in cancer treatment, breast cancer still remains the second most common cause of death from cancer in women. Doxorubicin (DOXO) is widely used for cancer treatment. However, drug resistance limits the treatment outcome. Here, we investigated the toxicity of DOXO in combination with an antifungal agent amphotericin B (AmB) against the MCF-7 breast cancer cell line. The cell viability was measured using MTT assay. The apoptosis was studied by caspase-8 and caspase-9 activity measurements and DNA fragmentation was investigated by TUNEL assay. The combination of two drugs significantly increased the apoptotic index and the caspase-8 and caspase-9 activities in comparison to DOXO-treated cells. Our finding showed that pre-treatment of MCF-7 cells with AmB synergistically exerted the anticancer effect of DOXO through the caspase-dependent apoptosis manner.

摘要

尽管癌症治疗有所改善,但乳腺癌仍是女性癌症死亡的第二大常见原因。阿霉素(DOXO)广泛用于癌症治疗。然而,耐药性限制了治疗效果。在此,我们研究了DOXO与抗真菌剂两性霉素B(AmB)联合对MCF-7乳腺癌细胞系的毒性。使用MTT法测量细胞活力。通过测量caspase-8和caspase-9活性研究细胞凋亡,并通过TUNEL法研究DNA片段化。与DOXO处理的细胞相比,两种药物的联合显著增加了凋亡指数以及caspase-8和caspase-9活性。我们的研究结果表明,用AmB预处理MCF-7细胞通过caspase依赖性凋亡方式协同发挥DOXO的抗癌作用。

相似文献

1
Amphotericin B potentiates the anticancer activity of doxorubicin on the MCF-7 breast cancer cells.
J Chem Biol. 2017 Jun 5;10(3):143-150. doi: 10.1007/s12154-017-0172-1. eCollection 2017 Jul.
4
Simvastatin potentiates doxorubicin activity against MCF-7 breast cancer cells.
Oncol Lett. 2017 Nov;14(5):6243-6250. doi: 10.3892/ol.2017.6783. Epub 2017 Aug 21.
5
PARP inhibition sensitizes p53-deficient breast cancer cells to doxorubicin-induced apoptosis.
Biochem J. 2005 Feb 15;386(Pt 1):119-25. doi: 10.1042/BJ20040776.
7
Change in TNF-alpha receptor expression is a relevant event in doxorubicin-induced H9c2 cardiomyocyte cell death.
J Interferon Cytokine Res. 2007 Jul;27(7):589-97. doi: 10.1089/jir.2006.0161.
10
The novel camptothecin derivative, CPT211, induces cell cycle arrest and apoptosis in models of human breast cancer.
Biomed Pharmacother. 2020 Aug;128:110309. doi: 10.1016/j.biopha.2020.110309. Epub 2020 Jun 4.

引用本文的文献

2
Antibacterial Profile of a Microbicidal Agent Targeting Tyrosine Phosphatases and Redox Thiols, Novel Drug Targets.
Antibiotics (Basel). 2021 Oct 27;10(11):1310. doi: 10.3390/antibiotics10111310.
3
Dacarbazine nanoparticle topical delivery system for the treatment of melanoma.
Sci Rep. 2017 Nov 28;7(1):16517. doi: 10.1038/s41598-017-16878-1.

本文引用的文献

1
Doxorubicin Changes Bax /Bcl-xL Ratio, Caspase-8 and 9 in Breast Cancer Cells.
Adv Pharm Bull. 2015 Sep;5(3):351-9. doi: 10.15171/apb.2015.049. Epub 2015 Sep 19.
2
Inhibitory and apoptosis-inducing effects of Newcastle disease virus strain AF2240 on mammary carcinoma cell line.
Biomed Res Int. 2015;2015:127828. doi: 10.1155/2015/127828. Epub 2015 Mar 2.
3
A simple and reliable approach for assessing anticancer activity in vitro.
Curr Med Chem. 2015;22(11):1324-34. doi: 10.2174/0929867322666150209150639.
5
Global cancer statistics, 2012.
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
7
Doxorubicin and lapatinib combination nanomedicine for treating resistant breast cancer.
Mol Pharm. 2014 Aug 4;11(8):2600-11. doi: 10.1021/mp400687w. Epub 2014 Jan 17.
9
Gene expression alterations in doxorubicin resistant MCF7 breast cancer cell line.
Genomics. 2013 Apr;101(4):213-20. doi: 10.1016/j.ygeno.2012.11.009. Epub 2012 Nov 30.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验